Halozyme Therapeutics
HALO
#2058
Rank
NZ$12.12 B
Marketcap
$95.71
Share price
-3.01%
Change (1 day)
43.83%
Change (1 year)

Halozyme Therapeutics (HALO) - Cash on Hand

Cash on Hand as of June 2024 : NZ$0.85 B

According to Halozyme Therapeutics's latest financial reports the company has NZ$0.85 B in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Halozyme Therapeutics - Cash on Hand chart (from 2002 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2023-12-31NZ$0.53 B-7.02%
2022-12-31NZ$0.57 B-47.18%
2021-12-31NZ$1.08 B111.43%
2020-12-31NZ$0.51 B-18.06%
2019-12-31NZ$0.62 B18.21%
2018-12-31NZ$0.52 B-20.04%
2017-12-31NZ$0.66 B123.26%
2016-12-31NZ$0.29 B86.73%
2015-12-31NZ$0.15 B-8.34%
2014-12-31NZ$0.17 B98.58%
2013-12-31NZ$87.06 M-28.27%
2012-12-31NZ$0.12 B79.31%
2011-12-31NZ$67.68 M-37.53%
2010-12-31NZ$0.10 B15.79%
2009-12-31NZ$93.56 M-15.28%
2008-12-31NZ$0.11 B-12.63%
2007-12-31NZ$0.12 B101.54%
2006-12-31NZ$62.72 M124.08%
2005-12-31NZ$27.99 M24.77%
2004-12-31NZ$22.43 M2795.89%
2003-12-31NZ$0.77 M316.9%
2002-12-31NZ$0.18 M195.33%
2001-12-31NZ$0.06 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
NZ$0.40 B-53.17%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$5.43 B 535.88%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$3.38 B 296.01%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.47 B 1,242.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$11.77 B 1,276.88%๐Ÿ‡ซ๐Ÿ‡ท France
NZ$41.17 B 4,715.42%๐Ÿ‡บ๐Ÿ‡ธ USA